The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but ...

Pfizer saw U.S. Comirnaty sales drop to $870 million in the recently completed third quarter from $1.16 billion in the same ...

The largest study of its kind has revealed that the Pfizer-BioNTech Covid-19 vaccine presents considerably fewer problems for ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

The risks after being infected with the virus "lasted much longer" compared with post-vaccination, researchers said ...

The largest study of its kind has shown the Pfizer-BioNTech Covid-19 vaccine causes far fewer problems than the virus itself ...

But Pfizer (PFE) isn't going down without a fight. While Novo Nordisk's (NVO) bid could top Pfizer's by up to $2.7 billion, Pfizer Chief Executive Albert Bourla called it "illusory" and said it can't ...

Pharmacists say there are so many problems with Alberta's COVID-19 vaccination campaign this year, they fear some people will choose not to get immunized.

Getting covid-19 for the first time slightly increased the risk of heart inflammation, blood clots and bleeding disorders among children, whereas being vaccinated against the virus was much safer and ...

The new study, spearheaded by experts at UCL and the universities of Cambridge and Edinburgh, with support from the BHF Data ...

The Pfizer-BioNTech Covid-19 vaccine causes rare complications in children and young people, according to the study ...